John Phillip Gingrey (born July 10, 1942) is an American physician and former politician who served as a U.S. Representative for Georgia's 11th congressional district from 2003 to 2015.

Since leaving Congress, Gingrey has worked as a senior adviser at the District Policy Group in Washington, D.C., which is the lobbying arm of the Drinker Biddle law firm.

On March 27, 2013, Gingrey announced he would be a candidate in the 2014 race for U.S. Senate in his home state,[3] he was unsuccessful, later losing in the May 20, 2014 Republican primary, placing fourth.

[citation needed] In his final campaign for his U.S. House seat in 2012, Gingrey defeated Democrat Patrick Thompson with 68.6 percent of the vote.

[citation needed] He is a founding member and co-chairman of the GOP Doctors Caucus, a group of 20 health care providers in the House of Representatives.

The Caucus utilizes their medical expertise to develop and advocate for patient-centered health care reforms focused on quality, access, affordability, portability, and choice.

[8] In 2008 Gingrey signed a pledge sponsored by Americans for Prosperity promising to vote against any global warming legislation that would raise taxes.

[9] In November 2011, it was reported that Gingrey allegedly received stock benefits, potentially in violation of congressional ethics rules, from his role as an investor and board member of two Georgia banks.

Akin had been running for the U.S. Senate from Missouri; his campaign fell apart after he said the debunked claim that "the female body has ways to try to shut that whole thing down."

[30] He remains a licensed physician who practices on a volunteer basis for low-income Georgians at the Good Samaritan Clinic in Smyrna, Georgia.

Hospitals must continually untie a tangle of HR, regulatory, budgetary and technology issues while delivering quality health care.

Gingrey argued that President Trump took a step toward promoting stability with his nomination of Alex Azar as the Secretary of Health and Human Services.

In the summer of 2016, Gingrey wrote an op-ed about the opioid epidemic occurring in the U.S. To combat the epidemic, Gingrey wrote that he favors wider access to Naloxone (commonly known by its brand name Narcan) to save people who have overdosed, supports the Comprehensive Addiction and Recovery Act (CARA) which had recently passed Congress, encourages more states to adopt the Good Samaritan laws (laws that provide immunity for those who call 911 if they are witnessing or attending to an overdose), and public awareness education campaigns.

During the debate over Obamacare, one key issue of concern for physicians serving in Congress (such as Gingrey) was the promotion and utilization of cost-effectiveness data and "comparative effectiveness research" (CER).

"We were concerned that such information would be used to support government takeover of the practice of medicine, and specifically that these types of analyses and studies would dictate decision-making to doctors," Gingrey wrote.